Clinical significance of cyclin D1 expression in non-small cell lung cancer;Kliniczne znaczenie ekspresji cykliny D1 w niedrobnokomórkowym raku płuca

Pneumonologia i Alergologia Polska

Volumn 73, Issue 3, 2005, Pages 297-300

  Dworakowska, Dorota ^a,b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Cyclin D1; Non small cell lung cancer

Indexed keywords

CYCLIN D1;

ANTIGEN EXPRESSION; CELL CYCLE ARREST; GENE AMPLIFICATION; HUMAN; LUNG NON SMALL CELL CANCER; PROTO ONCOGENE; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 33645985792     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Graziano S. L.: Non-small cell lung cancer: clinical value of new biological predictors. Lung Cancer. 1997, 17 Suppl 1, S37-58.
2. Akervall J. A. i wsp.: Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer. 1997, 79, 380-9.
3. Serrano M., Hannon G. J., Beach D.: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993, 366, 704-7.
4. Sellers W. R., Kaelin W. G., Jr.: Role of the retinoblastoma protein in the pathogenesis of human cancer. J Clin Oncol. 1997, 15, 3301-12.
5. Schafer K. A.: The cell cycle: a review. Vet Pathol. 1998, 35, 461-78.
6. Keyomarsi K., Pardee A. B.: Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci U S A. 1993, 90, 1112-6.
7. Zukerberg L. R. i wsp.: Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. Am J Clin Pathol. 1995, 103, 756-60.
8. Naitoh H. i wsp.: Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol. 1995, 146, 1161-9.
9. Nishio M. i wsp.: Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers. Clin Cancer Res. 1997, 3, 1051-8.
10. Marchetti A. i wsp.: Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer. Int J Cancer. 1998, 75, 187-92.
11. Betticher D. C. i wsp.: G1 control gene status is frequently altered in resectable non-small cell lung cancer. Int J Cancer. 1997, 74, 556-62.
12. Kwa H. B. i wsp.: The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer. Lung Cancer. 1996, 14, 207-17.
13. Mate J. L. i wsp.: Cyclin D1 overexpression in non-small cell lung carcinoma: correlation with Ki67 labelling index and poor cytoplasmic differentiation. J Pathol. 1996, 180, 395-9.
14. Caputi M. i wsp.: Prognostic role of cyclin D1 in non small cell lung cancer: an immunohistochemical analysis. Eur J Histochem. 1997, 41, 133-8.
15. Kotelnikov V. M. i wsp.: Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis. Clin Cancer Res. 1997, 3, 95-101.
16. Liukkonen T. i wsp.: Evaluation of p21WAF1/CIP1 and cyclin D1 expression in the progression of superficial bladder cancer. Finbladder Group. Urol Res. 2000, 28, 285-92.
17. Lukas J. i wsp.: DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol. 1994, 125, 625-38.
18. Muller H. i wsp.: Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA. 1994, 91, 2945-9.
19. Brambilla E. i wsp.: Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance. J Pathol. 1999, 188, 351-60.
20. Mishina T. i wsp.: Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome. Br J Cancer. 1999, 80, 1289-95.
21. Dworakowska D. i wsp.: Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC). J Cancer Res Clin Oncol. 2005, 131, 479-85.
22. Saitoh G. i wsp.: Prognostic significance of p21waf1, cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer. Oncol Rep. 2001, 8, 737-43.
23. Holland T. A. i wsp.: Subcellular localisation of cyclin D1 protein in colorectal tumours is associated with p21 (WAF1/ CIP1) expression and correlates with patient survival. Int J Cancer. 2001, 95, 302-6.
24. el-Deiry W. S. i wsp.: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 1994, 54, 1169-74.
25. el-Deiry W. S. i wsp.: WAF1, a potential mediator of p53 tumor suppression. Cell. 1993, 75, 817-25.
26. Roninson I. B.: Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett. 2002, 179, 1-14.
27. Jin M. i wsp.: Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II. Lung Cancer. 2001, 34, 207-18.
28. Keum J. S. i wsp.: Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer. Br J Cancer. 1999, 81, 127-32.
29. Ikehara M. i wsp.: Expression of cyclin D1 but not of cyclin E is an indicator of poor prognosis in small adenocarcinomas of the lung. Oncol Rep. 2003, 10, 137-9.
30. Volm M., Koomagi R.: Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival. Br J Cancer. 2000, 82, 1747-54.
31. Anton R. C. i wsp.: The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung. Mod Pathol. 2000, 13, 1167-72.
32. Nguyen V. N. i wsp.: Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2. Acta Histochem. 2000, 102, 323-38.
33. Gugger M. i wsp.: Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours. Lung Cancer. 2001, 33, 229-39.